Palmer TD, Ashby WJ, Lewis JD, Zijlstra A. Targeting tumor cell motility to prevent metastasis. Adv Drug Deliv Rev. 2011;63(8):568–81.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yano T, Okamoto T, Fukuyama S, Maehara Y. Therapeutic strategy for postoperative recurrence in patients with non-small cell lung cancer. World J Clin Oncol. 2014;5(5):1048–54.
Article
PubMed
PubMed Central
Google Scholar
Fidler IJ. The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer. 2003;3(6):453–8.
Article
CAS
PubMed
Google Scholar
Kedrin D, van Rheenen J, Hernandez L, Condeelis J, Segall JE. Cell motility and cytoskeletal regulation in invasion and metastasis. J Mammary Gland Biol Neoplasia. 2007;12(2–3):143–52.
Article
PubMed
Google Scholar
Yamaguchi H, Miki H, Takenawa T. Neural Wiskott-Aldrich syndrome protein is involved in hepatocyte growth factor-induced migration, invasion, and tubulogenesis of epithelial cells. Cancer Res. 2002;62(9):2503–9.
CAS
PubMed
Google Scholar
Parsons JT, Horwitz AR, Schwartz MA. Cell adhesion: integrating cytoskeletal dynamics and cellular tension. Nat Rev Mol Cell Biol. 2010;11(9):633–43.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mattila PK, Lappalainen P. Filopodia: molecular architecture and cellular functions. Nat Rev Mol Cell Biol. 2008;9(6):446–54.
Article
CAS
PubMed
Google Scholar
Paz H, Pathak N, Yang J. Invading one step at a time: the role of invadopodia in tumor metastasis. Oncogene. 2014;33(33):4193–202.
Article
CAS
PubMed
Google Scholar
Machesky LM. Lamellipodia and filopodia in metastasis and invasion. FEBS Lett. 2008;582(14):2102–11.
Article
CAS
PubMed
Google Scholar
Morris HT, Machesky LM. Actin cytoskeletal control during epithelial to mesenchymal transition: focus on the pancreas and intestinal tract. Br J Cancer. 2015;112(4):613–20.
Article
CAS
PubMed
PubMed Central
Google Scholar
Youssoufian H, McAfee M, Kwiatkowski DJ. Cloning and chromosomal localization of the human cytoskeletal alpha-actinin gene reveals linkage to the beta-spectrin gene. Am J Hum Genet. 1990;47(1):62–72.
CAS
PubMed
PubMed Central
Google Scholar
Beggs AH, Byers TJ, Knoll JH, Boyce FM, Bruns GA, Kunkel LM. Cloning and characterization of two human skeletal muscle alpha-actinin genes located on chromosomes 1 and 11. J Biol Chem. 1992;267(13):9281–8.
CAS
PubMed
Google Scholar
Honda K, Yamada T, Endo R, Ino Y, Gotoh M, Tsuda H, et al. Actinin-4, a novel actin-bundling protein associated with cell motility and cancer invasion. J Cell Biol. 1998;140(6):1383–93.
Article
CAS
PubMed
PubMed Central
Google Scholar
Otey CA, Carpen O. Alpha-actinin revisited: a fresh look at an old player. Cell Motil Cytoskelet. 2004;58(2):104–11.
Article
CAS
Google Scholar
Hsu KS, Kao HY. Alpha-actinin 4 and tumorigenesis of breast cancer. Vitam Horm. 2013;93:323–51.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sjoblom B, Salmazo A, Djinovic-Carugo K. Alpha-actinin structure and regulation. Cell Mol Life Sci CMLS. 2008;65(17):2688–701.
Article
CAS
PubMed
Google Scholar
Lopez-Novoa JM, Nieto MA. Inflammation and EMT: an alliance towards organ fibrosis and cancer progression. EMBO Mol Med. 2009;1(6–7):303–14.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ono M, Sakamoto M, Ino Y, Moriya Y, Sugihara K, Muto T, et al. Cancer cell morphology at the invasive front and expression of cell adhesion-related carbohydrate in the primary lesion of patients with colorectal carcinoma with liver metastasis. Cancer. 1996;78(6):1179–86.
Article
CAS
PubMed
Google Scholar
Hirohashi S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol. 1998;153(2):333–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hirohashi S, Kanai Y. Cell adhesion system and human cancer morphogenesis. Cancer Sci. 2003;94(7):575–81.
Article
CAS
PubMed
Google Scholar
Ino Y, Gotoh M, Sakamoto M, Tsukagoshi K, Hirohashi S. Dysadherin, a cancer-associated cell membrane glycoprotein, down-regulates E-cadherin and promotes metastasis. Proc Natl Acad Sci USA. 2002;99(1):365–70.
Article
CAS
PubMed
Google Scholar
Honda K, Yamada T, Hayashida Y, Idogawa M, Sato S, Hasegawa F, et al. Actinin-4 increases cell motility and promotes lymph node metastasis of colorectal cancer. Gastroenterology. 2005;128(1):51–62.
Article
CAS
PubMed
Google Scholar
Hayashida Y, Honda K, Idogawa M, Ino Y, Ono M, Tsuchida A, et al. E-cadherin regulates the association between beta-catenin and actinin-4. Cancer Res. 2005;65(19):8836–45.
Article
CAS
PubMed
Google Scholar
Kikuchi S, Honda K, Tsuda H, Hiraoka N, Imoto I, Kosuge T, et al. Expression and gene amplification of actinin-4 in invasive ductal carcinoma of the pancreas. Clin Cancer Res Off J Am Assoc Cancer Res. 2008;14(17):5348–56.
Article
CAS
Google Scholar
Welsch T, Keleg S, Bergmann F, Bauer S, Hinz U, Schmidt J. Actinin-4 expression in primary and metastasized pancreatic ductal adenocarcinoma. Pancreas. 2009;38(8):968–76.
Article
CAS
PubMed
Google Scholar
Yamamoto S, Tsuda H, Honda K, Kita T, Takano M, Tamai S, et al. Actinin-4 expression in ovarian cancer: a novel prognostic indicator independent of clinical stage and histological type. Mod Pathol Off J US Can Acad Pathol Inc. 2007;20(12):1278–85.
CAS
Google Scholar
Agarwal N, Adhikari AS, Iyer SV, Hekmatdoost K, Welch DR, Iwakuma T. MTBP suppresses cell migration and filopodia formation by inhibiting ACTN4. Oncogene. 2013;32(4):462–70.
Article
CAS
PubMed
Google Scholar
Iwakuma T, Agarwal N. MDM2 binding protein, a novel metastasis suppressor. Cancer Metastasis Rev. 2012;31(3–4):633–40.
Article
CAS
PubMed
Google Scholar
Iwakuma T, Lozano G. MDM2, an introduction. Mol Cancer Res MCR. 2003;1(14):993–1000.
CAS
PubMed
Google Scholar
Honda K, Yamada T, Seike M, Hayashida Y, Idogawa M, Kondo T, et al. Alternative splice variant of actinin-4 in small cell lung cancer. Oncogene. 2004;23(30):5257–62.
Article
CAS
PubMed
Google Scholar
Yamagata N, Shyr Y, Yanagisawa K, Edgerton M, Dang TP, Gonzalez A, et al. A training-testing approach to the molecular classification of resected non-small cell lung cancer. Clin Cancer Res Off J Am Assoc Cancer Res. 2003;9(13):4695–704.
CAS
Google Scholar
Noro R, Honda K, Tsuta K, Ishii G, Maeshima AM, Miura N, et al. Distinct outcome of stage I lung adenocarcinoma with ACTN4 cell motility gene amplification. Ann Oncol Off J Eur Soc Med Oncol ESMO. 2013;24(10):2594–600.
Article
CAS
Google Scholar
Miyanaga A, Honda K, Tsuta K, Masuda M, Yamaguchi U, Fujii G, et al. Diagnostic and prognostic significance of the alternatively spliced ACTN4 variant in high-grade neuroendocrine pulmonary tumours. Ann Oncol Off J Eur Soc Med Oncol ESMO. 2013;24(1):84–90.
Article
CAS
Google Scholar
Yamada S, Yanamoto S, Yoshida H, Yoshitomi I, Kawasaki G, Mizuno A, et al. RNAi-mediated down-regulation of alpha-actinin-4 decreases invasion potential in oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2010;39(1):61–7.
Article
CAS
PubMed
Google Scholar
Watabe Y, Mori T, Yoshimoto S, Nomura T, Shibahara T, Yamada T, et al. Copy number increase of ACTN4 is a prognostic indicator in salivary gland carcinoma. Cancer Med. 2014;3(3):613–22.
Article
CAS
PubMed
PubMed Central
Google Scholar
Koizumi T, Nakatsuji H, Fukawa T, Avirmed S, Fukumori T, Takahashi M, et al. The role of actinin-4 in bladder cancer invasion. Urology. 2010;75(2):357–64.
Article
PubMed
Google Scholar
Yoshii H, Ito K, Asano T, Horiguchi A, Hayakawa M, Asano T. Increased expression of alpha-actinin-4 is associated with unfavorable pathological features and invasiveness of bladder cancer. Oncol Rep. 2013;30(3):1073–80.
CAS
PubMed
Google Scholar
Fu L, Qin YR, Xie D, Chow HY, Ngai SM, Kwong DL, et al. Identification of alpha-actinin 4 and 67 kDa laminin receptor as stage-specific markers in esophageal cancer via proteomic approaches. Cancer. 2007;110(12):2672–81.
Article
CAS
PubMed
Google Scholar
Bellacosa A, de Feo D, Godwin AK, Bell DW, Cheng JQ, Altomare DA, et al. Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. Int J Cancer. 1995;64(4):280–5.
Article
CAS
PubMed
Google Scholar
Cheng JQ, Godwin AK, Bellacosa A, Taguchi T, Franke TF, Hamilton TC, et al. AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas. Proc Natl Acad Sci USA. 1992;89(19):9267–71.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kallioniemi A, Kallioniemi OP, Piper J, Tanner M, Stokke T, Chen L, et al. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci USA. 1994;91(6):2156–60.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kim TM, Yim SH, Lee JS, Kwon MS, Ryu JW, Kang HM, et al. Genome-wide screening of genomic alterations and their clinicopathologic implications in non-small cell lung cancers. Clin Cancer Res Off J Am Assoc Cancer Res. 2005;11(23):8235–42.
Article
CAS
Google Scholar
Rao PH, Arias-Pulido H, Lu XY, Harris CP, Vargas H, Zhang FF, et al. Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma. BMC Cancer. 2004;4:5.
Article
PubMed
PubMed Central
Google Scholar
Ried T, Petersen I, Holtgreve-Grez H, Speicher MR, Schrock E, du Manoir S, et al. Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization. Cancer Res. 1994;54(7):1801–6.
CAS
PubMed
Google Scholar
Staal SP. Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma. Proc Natl Acad Sci USA. 1987;84(14):5034–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tang TC, Sham JS, Xie D, Fang Y, Huo KK, Wu QL, et al. Identification of a candidate oncogene SEI-1 within a minimal amplified region at 19q13.1 in ovarian cancer cell lines. Cancer Res. 2002;62(24):7157–61.
CAS
PubMed
Google Scholar
Thompson FH, Nelson MA, Trent JM, Guan XY, Liu Y, Yang JM, et al. Amplification of 19q13.1-q13.2 sequences in ovarian cancer. G-band, FISH, and molecular studies. Cancer Genet Cytogenet. 1996;87(1):55–62.
Article
CAS
PubMed
Google Scholar
Yamamoto S, Tsuda H, Honda K, Onozato K, Takano M, Tamai S, et al. Actinin-4 gene amplification in ovarian cancer: a candidate oncogene associated with poor patient prognosis and tumor chemoresistance. Mod Pathol Off J US Can Acad Pathol Inc. 2009;22(4):499–507.
CAS
Google Scholar
Yamamoto S, Tsuda H, Honda K, Takano M, Tamai S, Imoto I, et al. ACTN4 gene amplification and actinin-4 protein overexpression drive tumour development and histological progression in a high-grade subset of ovarian clear-cell adenocarcinomas. Histopathology. 2012;60(7):1073–83.
Article
PubMed
Google Scholar
Strauss GM, Herndon JE 2nd, Maddaus MA, Johnstone DW, Johnson EA, Harpole DH, et al. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. J Clin Oncol Off J Am Soc Clin Oncol. 2008;26(31):5043–51.
Article
CAS
Google Scholar
Pisters KM, Evans WK, Azzoli CG, Kris MG, Smith CA, Desch CE, et al. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline. J Clin Oncol Off J Am Soc Clin Oncol. 2007;25(34):5506–18.
Article
Google Scholar
Pignon JP, Tribodet H, Scagliotti GV, Douillard JY, Shepherd FA, Stephens RJ, et al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol Off J Am Soc Clin Oncol. 2008;26(21):3552–9.
Article
Google Scholar
Chauffert B, Mornex F, Bonnetain F, Rougier P, Mariette C, Bouche O, et al. Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study. Ann Oncol Off J Eur Soc Med Oncol ESMO. 2008;19(9):1592–9.
Article
CAS
Google Scholar
Loehrer PJ Sr, Feng Y, Cardenes H, Wagner L, Brell JM, Cella D, et al. Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial. J Clin Oncol Off J Am Soc Clin Oncol. 2011;29(31):4105–12.
Article
CAS
Google Scholar
Savir G, Huber KE, Saif MW. Locally advanced pancreatic cancer. Looking beyond traditional chemotherapy and radiation. JOP J Pancreas. 2013;14(4):337–9.
Google Scholar
Mian OY, Ram AN, Tuli R, Herman JM. Management options in locally advanced pancreatic cancer. Curr Oncol Rep. 2014;16(6):388.
Article
PubMed
Google Scholar
Watanabe T, Ueno H, Watabe Y, Hiraoka N, Morizane C, Itami J, et al. ACTN4 copy number increase as a predictive biomarker for chemoradiotherapy of locally advanced pancreatic cancer. Br J Cancer. 2015;112(4):704–13.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kaplan J, Pollak MR. Familial focal segmental glomerulosclerosis. Curr Opin Nephrol Hypertens. 2001;10(2):183–7.
Article
CAS
PubMed
Google Scholar
Kaplan JM, Kim SH, North KN, Rennke H, Correia LA, Tong HQ, et al. Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet. 2000;24(3):251–6.
Article
CAS
PubMed
Google Scholar
Ribeiro Ede A, N Pinotsis Jr, Ghisleni A, Salmazo A, Konarev PV, Kostan J, et al. The structure and regulation of human muscle alpha-actinin. Cell. 2014;159(6):1447–60.
Article
PubMed
Google Scholar
Lee SH, Weins A, Hayes DB, Pollak MR, Dominguez R. Crystal structure of the actin-binding domain of alpha-actinin-4 Lys255Glu mutant implicated in focal segmental glomerulosclerosis. J Mol Biol. 2008;376(2):317–24.
Article
CAS
PubMed
Google Scholar
Liu J, Taylor DW, Taylor KA. A 3-D reconstruction of smooth muscle alpha-actinin by CryoEm reveals two different conformations at the actin-binding region. J Mol Biol. 2004;338(1):115–25.
Article
CAS
PubMed
Google Scholar
Galkin VE, Orlova A, Salmazo A, Djinovic-Carugo K, Egelman EH. Opening of tandem calponin homology domains regulates their affinity for F-actin. Nat Struct Mol Biol. 2010;17(5):614–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ehrlicher AJ, Krishnan R, Guo M, Bidan CM, Weitz DA, Pollak MR. Alpha-actinin binding kinetics modulate cellular dynamics and force generation. In: Proceedings of the National Academy of Sciences of the United States of America. 2015 Apr 27. pii: 201505652. [Epub ahead of print].
Chakraborty S, Reineke EL, Lam M, Li X, Liu Y, Gao C, et al. Alpha-actinin 4 potentiates myocyte enhancer factor-2 transcription activity by antagonizing histone deacetylase 7. J Biol Chem. 2006;281(46):35070–80.
Article
CAS
PubMed
Google Scholar
Mangelsdorf DJ, Evans RM. The RXR heterodimers and orphan receptors. Cell. 1995;83(6):841–50.
Article
CAS
PubMed
Google Scholar
Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, et al. The nuclear receptor superfamily: the second decade. Cell. 1995;83(6):835–9.
Article
CAS
PubMed
Google Scholar
Francis GA, Fayard E, Picard F, Auwerx J. Nuclear receptors and the control of metabolism. Annu Rev Physiol. 2003;65:261–311.
Article
CAS
PubMed
Google Scholar
Jordan VC, Brodie AM. Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer. Steroids. 2007;72(1):7–25.
Article
CAS
PubMed
Google Scholar
Khurana S, Chakraborty S, Cheng X, Su YT, Kao HY. The actin-binding protein, actinin alpha 4 (ACTN4), is a nuclear receptor coactivator that promotes proliferation of MCF-7 breast cancer cells. J Biol Chem. 2011;286(3):1850–9.
Article
CAS
PubMed
Google Scholar
Khurana S, Chakraborty S, Zhao X, Liu Y, Guan D, Lam M, et al. Identification of a novel LXXLL motif in alpha-actinin 4-spliced isoform that is critical for its interaction with estrogen receptor alpha and co-activators. J Biol Chem. 2012;287(42):35418–29.
Article
CAS
PubMed
PubMed Central
Google Scholar
DiDonato JA, Mercurio F, Karin M. NF-kappaB and the link between inflammation and cancer. Immunol Rev. 2012;246(1):379–400.
Article
PubMed
Google Scholar
Tornatore L, Thotakura AK, Bennett J, Moretti M, Franzoso G. The nuclear factor kappa B signaling pathway: integrating metabolism with inflammation. Trends Cell Biol. 2012;22(11):557–66.
Article
CAS
PubMed
Google Scholar
Babakov VN, Petukhova OA, Turoverova LV, Kropacheva IV, Tentler DG, Bolshakova AV, et al. RelA/NF-kappaB transcription factor associates with alpha-actinin-4. Exp Cell Res. 2008;314(5):1030–8.
Article
CAS
PubMed
Google Scholar
Zhao X, Hsu KS, Lim JH, Bruggeman LA, Kao HY. Alpha-Actinin 4 potentiates nuclear factor kappa-light-chain-enhancer of activated B-cell (NF-kappaB) activity in podocytes independent of its cytoplasmic actin binding function. J Biol Chem. 2015;290(1):338–49.
Article
CAS
PubMed
Google Scholar
Fukami K, Sawada N, Endo T, Takenawa T. Identification of a phosphatidylinositol 4,5-bisphosphate-binding site in chicken skeletal muscle alpha-actinin. J Biol Chem. 1996;271(5):2646–50.
Article
CAS
PubMed
Google Scholar
Shibasaki F, Fukami K, Fukui Y, Takenawa T. Phosphatidylinositol 3-kinase binds to alpha-actinin through the p85 subunit. Biochem J. 1994;302(Pt 2):551–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ding Z, Liang J, Lu Y, Yu Q, Songyang Z, Lin SY, et al. A retrovirus-based protein complementation assay screen reveals functional AKT1-binding partners. Proc Natl Acad Sci USA. 2006;103(41):15014–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Khurana S, Chakraborty S, Lam M, Liu Y, Su YT, Zhao X, et al. Familial focal segmental glomerulosclerosis (FSGS)-linked alpha-actinin 4 (ACTN4) protein mutants lose ability to activate transcription by nuclear hormone receptors. J Biol Chem. 2012;287(15):12027–35.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jasavala R, Martinez H, Thumar J, Andaya A, Gingras AC, Eng JK, et al. Identification of putative androgen receptor interaction protein modules: cytoskeleton and endosomes modulate androgen receptor signaling in prostate cancer cells. Mol Cell Proteomics : MCP. 2007;6(2):252–71.
Article
CAS
PubMed
Google Scholar
Fukushima S, Yoshida A, Honda K, Maeshima AM, Narita Y, Yamada T, et al. Immunohistochemical actinin-4 expression in infiltrating gliomas: association with WHO grade and differentiation. Brain Tumor Pathol. 2014;31(1):11–6.
Article
CAS
PubMed
Google Scholar
Henry WI, Dubois J, Quick QA. The microtubule inhibiting agent epothilone B antagonizes glioma cell motility associated with reorganization of the actin-binding protein alpha-actinin 4. Oncol Rep. 2011;25(3):887–93.
CAS
PubMed
Google Scholar
Quick Q, Skalli O. Alpha-actinin 1 and alpha-actinin 4: contrasting roles in the survival, motility, and RhoA signaling of astrocytoma cells. Exp Cell Res. 2010;316(7):1137–47.
Article
CAS
PubMed
Google Scholar
Tanaka N, Yamashita T, Yamamoto S, Matsunobu T, Tsuda H, Honda K, et al. Histological growth pattern of and alpha-actinin-4 expression in thyroid cancer. Anticancer Res. 2014;34(6):3157–63.
PubMed
Google Scholar
Wang MC, Chang YH, Wu CC, Tyan YC, Chang HC, Goan YG, et al. Alpha-actinin 4 is associated with cancer cell motility and is a potential biomarker in non-small cell lung cancer. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2015;10(2):286–301.
CAS
Google Scholar
Nowee ME, Snijders AM, Rockx DA, de Wit RM, Kosma VM, Hamalainen K, et al. DNA profiling of primary serous ovarian and fallopian tube carcinomas with array comparative genomic hybridization and multiplex ligation-dependent probe amplification. J Pathol. 2007;213(1):46–55.
Article
CAS
PubMed
Google Scholar
Shao H, Li S, Watkins SC, Wells A. Alpha-Actinin-4 is required for amoeboid-type invasiveness of melanoma cells. J Biol Chem. 2014;289(47):32717–28.
Article
CAS
PubMed
PubMed Central
Google Scholar
Burmeister T, Meyer C, Schwartz S, Hofmann J, Molkentin M, Kowarz E, et al. The MLL recombinome of adult CD10-negative B-cell precursor acute lymphoblastic leukemia: results from the GMALL study group. Blood. 2009;113(17):4011–5.
Article
CAS
PubMed
Google Scholar
Yang JJ, Park TS, Lee ST, Seo JY, Oh SH, Cho EH, et al. Molecular characterization and clinical course of MLL-ACTN4 rearrangement in therapy-related hematologic malignancies. Haematologica. 2014;99(4):e49–51.
Article
PubMed
PubMed Central
Google Scholar